Global Palonosetron Market Growth 2025-2031
The global Palonosetron market size is predicted to grow from US$ 122 million in 2025 to US$ 157 million in 2031; it is expected to grow at a CAGR of 4.3% from 2025 to 2031.
The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.
Palonosetron (INN, trade name Aloxi) is a 5-HT3 antagonist used in the prevention and treatment of chemotherapy-induced nausea and vomiting (CINV).
Palonosetron is a medication used to prevent nausea and vomiting caused by chemotherapy and surgery. It belongs to a class of drugs called 5-HT3 receptor antagonists, which inhibit the action of serotonin, a chemical in the body that triggers nausea and vomiting. The increasing incidence of cancer worldwide is a major driver for the palonosetron market. As more and more patients undergo chemotherapy, there is a growing need to manage side effects such as nausea and vomiting. With growing awareness about cancer treatment, patients, caretakers, and healthcare providers are seeking better prevention and management of chemotherapy-induced side effects. This drives the demand for medications like palonosetron. Technological advancements in healthcare have led to better detection and treatment of cancer. This has resulted in increased adoption of chemotherapy, leading to a higher demand for medications like palonosetron. While palonosetron is effective, there are other medications available for managing chemotherapy-induced nausea and vomiting. Competition among different medications in the market can drive innovation, resulting in increased demand for palonosetron. Higher healthcare expenditure and accessibility to healthcare facilities in many regions further contribute to the growth of the palonosetron market.
LP Information, Inc. (LPI) ' newest research report, the “Palonosetron Industry Forecast” looks at past sales and reviews total world Palonosetron sales in 2024, providing a comprehensive analysis by region and market sector of projected Palonosetron sales for 2025 through 2031. With Palonosetron sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Palonosetron industry.
This Insight Report provides a comprehensive analysis of the global Palonosetron landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Palonosetron portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Palonosetron market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Palonosetron and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Palonosetron.
This report presents a comprehensive overview, market shares, and growth opportunities of Palonosetron market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Palonosetron market?
What factors are driving Palonosetron market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Palonosetron market opportunities vary by end market size?
How does Palonosetron break out by Type, by Application?
The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.
Palonosetron (INN, trade name Aloxi) is a 5-HT3 antagonist used in the prevention and treatment of chemotherapy-induced nausea and vomiting (CINV).
Palonosetron is a medication used to prevent nausea and vomiting caused by chemotherapy and surgery. It belongs to a class of drugs called 5-HT3 receptor antagonists, which inhibit the action of serotonin, a chemical in the body that triggers nausea and vomiting. The increasing incidence of cancer worldwide is a major driver for the palonosetron market. As more and more patients undergo chemotherapy, there is a growing need to manage side effects such as nausea and vomiting. With growing awareness about cancer treatment, patients, caretakers, and healthcare providers are seeking better prevention and management of chemotherapy-induced side effects. This drives the demand for medications like palonosetron. Technological advancements in healthcare have led to better detection and treatment of cancer. This has resulted in increased adoption of chemotherapy, leading to a higher demand for medications like palonosetron. While palonosetron is effective, there are other medications available for managing chemotherapy-induced nausea and vomiting. Competition among different medications in the market can drive innovation, resulting in increased demand for palonosetron. Higher healthcare expenditure and accessibility to healthcare facilities in many regions further contribute to the growth of the palonosetron market.
LP Information, Inc. (LPI) ' newest research report, the “Palonosetron Industry Forecast” looks at past sales and reviews total world Palonosetron sales in 2024, providing a comprehensive analysis by region and market sector of projected Palonosetron sales for 2025 through 2031. With Palonosetron sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Palonosetron industry.
This Insight Report provides a comprehensive analysis of the global Palonosetron landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Palonosetron portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Palonosetron market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Palonosetron and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Palonosetron.
This report presents a comprehensive overview, market shares, and growth opportunities of Palonosetron market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Injection 0.25 mg/5 mL
- Injection 20 mcg/kg (max 1.5 mg)
- Adults
- Children
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Helsinn Therapeutics
- Teva
- Dr. Reddys Laboratories
- Cipla
- Pfizer
- Sagent Pharmaceuticals
- Fresenius Kabi
- Qilu Pharmaceutical
- Jiangsu Aosaikang Pharmaceutical
- Sichuan Hairong Pharmaceutical
- Exela Pharma
What is the 10-year outlook for the global Palonosetron market?
What factors are driving Palonosetron market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Palonosetron market opportunities vary by end market size?
How does Palonosetron break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Palonosetron Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Palonosetron by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Palonosetron by Country/Region, 2020, 2024 & 2031
2.2 Palonosetron Segment by Type
2.2.1 Injection 0.25 mg/5 mL
2.2.2 Injection 20 mcg/kg (max 1.5 mg)
2.3 Palonosetron Sales by Type
2.3.1 Global Palonosetron Sales Market Share by Type (2020-2025)
2.3.2 Global Palonosetron Revenue and Market Share by Type (2020-2025)
2.3.3 Global Palonosetron Sale Price by Type (2020-2025)
2.4 Palonosetron Segment by Application
2.4.1 Adults
2.4.2 Children
2.5 Palonosetron Sales by Application
2.5.1 Global Palonosetron Sale Market Share by Application (2020-2025)
2.5.2 Global Palonosetron Revenue and Market Share by Application (2020-2025)
2.5.3 Global Palonosetron Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Palonosetron Breakdown Data by Company
3.1.1 Global Palonosetron Annual Sales by Company (2020-2025)
3.1.2 Global Palonosetron Sales Market Share by Company (2020-2025)
3.2 Global Palonosetron Annual Revenue by Company (2020-2025)
3.2.1 Global Palonosetron Revenue by Company (2020-2025)
3.2.2 Global Palonosetron Revenue Market Share by Company (2020-2025)
3.3 Global Palonosetron Sale Price by Company
3.4 Key Manufacturers Palonosetron Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Palonosetron Product Location Distribution
3.4.2 Players Palonosetron Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR PALONOSETRON BY GEOGRAPHIC REGION
4.1 World Historic Palonosetron Market Size by Geographic Region (2020-2025)
4.1.1 Global Palonosetron Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Palonosetron Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Palonosetron Market Size by Country/Region (2020-2025)
4.2.1 Global Palonosetron Annual Sales by Country/Region (2020-2025)
4.2.2 Global Palonosetron Annual Revenue by Country/Region (2020-2025)
4.3 Americas Palonosetron Sales Growth
4.4 APAC Palonosetron Sales Growth
4.5 Europe Palonosetron Sales Growth
4.6 Middle East & Africa Palonosetron Sales Growth
5 AMERICAS
5.1 Americas Palonosetron Sales by Country
5.1.1 Americas Palonosetron Sales by Country (2020-2025)
5.1.2 Americas Palonosetron Revenue by Country (2020-2025)
5.2 Americas Palonosetron Sales by Type (2020-2025)
5.3 Americas Palonosetron Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Palonosetron Sales by Region
6.1.1 APAC Palonosetron Sales by Region (2020-2025)
6.1.2 APAC Palonosetron Revenue by Region (2020-2025)
6.2 APAC Palonosetron Sales by Type (2020-2025)
6.3 APAC Palonosetron Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Palonosetron by Country
7.1.1 Europe Palonosetron Sales by Country (2020-2025)
7.1.2 Europe Palonosetron Revenue by Country (2020-2025)
7.2 Europe Palonosetron Sales by Type (2020-2025)
7.3 Europe Palonosetron Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Palonosetron by Country
8.1.1 Middle East & Africa Palonosetron Sales by Country (2020-2025)
8.1.2 Middle East & Africa Palonosetron Revenue by Country (2020-2025)
8.2 Middle East & Africa Palonosetron Sales by Type (2020-2025)
8.3 Middle East & Africa Palonosetron Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Palonosetron
10.3 Manufacturing Process Analysis of Palonosetron
10.4 Industry Chain Structure of Palonosetron
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Palonosetron Distributors
11.3 Palonosetron Customer
12 WORLD FORECAST REVIEW FOR PALONOSETRON BY GEOGRAPHIC REGION
12.1 Global Palonosetron Market Size Forecast by Region
12.1.1 Global Palonosetron Forecast by Region (2026-2031)
12.1.2 Global Palonosetron Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Palonosetron Forecast by Type (2026-2031)
12.7 Global Palonosetron Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Helsinn Therapeutics
13.1.1 Helsinn Therapeutics Company Information
13.1.2 Helsinn Therapeutics Palonosetron Product Portfolios and Specifications
13.1.3 Helsinn Therapeutics Palonosetron Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Helsinn Therapeutics Main Business Overview
13.1.5 Helsinn Therapeutics Latest Developments
13.2 Teva
13.2.1 Teva Company Information
13.2.2 Teva Palonosetron Product Portfolios and Specifications
13.2.3 Teva Palonosetron Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Teva Main Business Overview
13.2.5 Teva Latest Developments
13.3 Dr. Reddys Laboratories
13.3.1 Dr. Reddys Laboratories Company Information
13.3.2 Dr. Reddys Laboratories Palonosetron Product Portfolios and Specifications
13.3.3 Dr. Reddys Laboratories Palonosetron Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Dr. Reddys Laboratories Main Business Overview
13.3.5 Dr. Reddys Laboratories Latest Developments
13.4 Cipla
13.4.1 Cipla Company Information
13.4.2 Cipla Palonosetron Product Portfolios and Specifications
13.4.3 Cipla Palonosetron Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Cipla Main Business Overview
13.4.5 Cipla Latest Developments
13.5 Pfizer
13.5.1 Pfizer Company Information
13.5.2 Pfizer Palonosetron Product Portfolios and Specifications
13.5.3 Pfizer Palonosetron Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Pfizer Main Business Overview
13.5.5 Pfizer Latest Developments
13.6 Sagent Pharmaceuticals
13.6.1 Sagent Pharmaceuticals Company Information
13.6.2 Sagent Pharmaceuticals Palonosetron Product Portfolios and Specifications
13.6.3 Sagent Pharmaceuticals Palonosetron Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Sagent Pharmaceuticals Main Business Overview
13.6.5 Sagent Pharmaceuticals Latest Developments
13.7 Fresenius Kabi
13.7.1 Fresenius Kabi Company Information
13.7.2 Fresenius Kabi Palonosetron Product Portfolios and Specifications
13.7.3 Fresenius Kabi Palonosetron Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Fresenius Kabi Main Business Overview
13.7.5 Fresenius Kabi Latest Developments
13.8 Qilu Pharmaceutical
13.8.1 Qilu Pharmaceutical Company Information
13.8.2 Qilu Pharmaceutical Palonosetron Product Portfolios and Specifications
13.8.3 Qilu Pharmaceutical Palonosetron Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Qilu Pharmaceutical Main Business Overview
13.8.5 Qilu Pharmaceutical Latest Developments
13.9 Jiangsu Aosaikang Pharmaceutical
13.9.1 Jiangsu Aosaikang Pharmaceutical Company Information
13.9.2 Jiangsu Aosaikang Pharmaceutical Palonosetron Product Portfolios and Specifications
13.9.3 Jiangsu Aosaikang Pharmaceutical Palonosetron Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Jiangsu Aosaikang Pharmaceutical Main Business Overview
13.9.5 Jiangsu Aosaikang Pharmaceutical Latest Developments
13.10 Sichuan Hairong Pharmaceutical
13.10.1 Sichuan Hairong Pharmaceutical Company Information
13.10.2 Sichuan Hairong Pharmaceutical Palonosetron Product Portfolios and Specifications
13.10.3 Sichuan Hairong Pharmaceutical Palonosetron Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Sichuan Hairong Pharmaceutical Main Business Overview
13.10.5 Sichuan Hairong Pharmaceutical Latest Developments
13.11 Exela Pharma
13.11.1 Exela Pharma Company Information
13.11.2 Exela Pharma Palonosetron Product Portfolios and Specifications
13.11.3 Exela Pharma Palonosetron Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Exela Pharma Main Business Overview
13.11.5 Exela Pharma Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Palonosetron Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Palonosetron by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Palonosetron by Country/Region, 2020, 2024 & 2031
2.2 Palonosetron Segment by Type
2.2.1 Injection 0.25 mg/5 mL
2.2.2 Injection 20 mcg/kg (max 1.5 mg)
2.3 Palonosetron Sales by Type
2.3.1 Global Palonosetron Sales Market Share by Type (2020-2025)
2.3.2 Global Palonosetron Revenue and Market Share by Type (2020-2025)
2.3.3 Global Palonosetron Sale Price by Type (2020-2025)
2.4 Palonosetron Segment by Application
2.4.1 Adults
2.4.2 Children
2.5 Palonosetron Sales by Application
2.5.1 Global Palonosetron Sale Market Share by Application (2020-2025)
2.5.2 Global Palonosetron Revenue and Market Share by Application (2020-2025)
2.5.3 Global Palonosetron Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Palonosetron Breakdown Data by Company
3.1.1 Global Palonosetron Annual Sales by Company (2020-2025)
3.1.2 Global Palonosetron Sales Market Share by Company (2020-2025)
3.2 Global Palonosetron Annual Revenue by Company (2020-2025)
3.2.1 Global Palonosetron Revenue by Company (2020-2025)
3.2.2 Global Palonosetron Revenue Market Share by Company (2020-2025)
3.3 Global Palonosetron Sale Price by Company
3.4 Key Manufacturers Palonosetron Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Palonosetron Product Location Distribution
3.4.2 Players Palonosetron Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR PALONOSETRON BY GEOGRAPHIC REGION
4.1 World Historic Palonosetron Market Size by Geographic Region (2020-2025)
4.1.1 Global Palonosetron Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Palonosetron Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Palonosetron Market Size by Country/Region (2020-2025)
4.2.1 Global Palonosetron Annual Sales by Country/Region (2020-2025)
4.2.2 Global Palonosetron Annual Revenue by Country/Region (2020-2025)
4.3 Americas Palonosetron Sales Growth
4.4 APAC Palonosetron Sales Growth
4.5 Europe Palonosetron Sales Growth
4.6 Middle East & Africa Palonosetron Sales Growth
5 AMERICAS
5.1 Americas Palonosetron Sales by Country
5.1.1 Americas Palonosetron Sales by Country (2020-2025)
5.1.2 Americas Palonosetron Revenue by Country (2020-2025)
5.2 Americas Palonosetron Sales by Type (2020-2025)
5.3 Americas Palonosetron Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Palonosetron Sales by Region
6.1.1 APAC Palonosetron Sales by Region (2020-2025)
6.1.2 APAC Palonosetron Revenue by Region (2020-2025)
6.2 APAC Palonosetron Sales by Type (2020-2025)
6.3 APAC Palonosetron Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Palonosetron by Country
7.1.1 Europe Palonosetron Sales by Country (2020-2025)
7.1.2 Europe Palonosetron Revenue by Country (2020-2025)
7.2 Europe Palonosetron Sales by Type (2020-2025)
7.3 Europe Palonosetron Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Palonosetron by Country
8.1.1 Middle East & Africa Palonosetron Sales by Country (2020-2025)
8.1.2 Middle East & Africa Palonosetron Revenue by Country (2020-2025)
8.2 Middle East & Africa Palonosetron Sales by Type (2020-2025)
8.3 Middle East & Africa Palonosetron Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Palonosetron
10.3 Manufacturing Process Analysis of Palonosetron
10.4 Industry Chain Structure of Palonosetron
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Palonosetron Distributors
11.3 Palonosetron Customer
12 WORLD FORECAST REVIEW FOR PALONOSETRON BY GEOGRAPHIC REGION
12.1 Global Palonosetron Market Size Forecast by Region
12.1.1 Global Palonosetron Forecast by Region (2026-2031)
12.1.2 Global Palonosetron Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Palonosetron Forecast by Type (2026-2031)
12.7 Global Palonosetron Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Helsinn Therapeutics
13.1.1 Helsinn Therapeutics Company Information
13.1.2 Helsinn Therapeutics Palonosetron Product Portfolios and Specifications
13.1.3 Helsinn Therapeutics Palonosetron Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Helsinn Therapeutics Main Business Overview
13.1.5 Helsinn Therapeutics Latest Developments
13.2 Teva
13.2.1 Teva Company Information
13.2.2 Teva Palonosetron Product Portfolios and Specifications
13.2.3 Teva Palonosetron Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Teva Main Business Overview
13.2.5 Teva Latest Developments
13.3 Dr. Reddys Laboratories
13.3.1 Dr. Reddys Laboratories Company Information
13.3.2 Dr. Reddys Laboratories Palonosetron Product Portfolios and Specifications
13.3.3 Dr. Reddys Laboratories Palonosetron Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Dr. Reddys Laboratories Main Business Overview
13.3.5 Dr. Reddys Laboratories Latest Developments
13.4 Cipla
13.4.1 Cipla Company Information
13.4.2 Cipla Palonosetron Product Portfolios and Specifications
13.4.3 Cipla Palonosetron Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Cipla Main Business Overview
13.4.5 Cipla Latest Developments
13.5 Pfizer
13.5.1 Pfizer Company Information
13.5.2 Pfizer Palonosetron Product Portfolios and Specifications
13.5.3 Pfizer Palonosetron Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Pfizer Main Business Overview
13.5.5 Pfizer Latest Developments
13.6 Sagent Pharmaceuticals
13.6.1 Sagent Pharmaceuticals Company Information
13.6.2 Sagent Pharmaceuticals Palonosetron Product Portfolios and Specifications
13.6.3 Sagent Pharmaceuticals Palonosetron Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Sagent Pharmaceuticals Main Business Overview
13.6.5 Sagent Pharmaceuticals Latest Developments
13.7 Fresenius Kabi
13.7.1 Fresenius Kabi Company Information
13.7.2 Fresenius Kabi Palonosetron Product Portfolios and Specifications
13.7.3 Fresenius Kabi Palonosetron Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Fresenius Kabi Main Business Overview
13.7.5 Fresenius Kabi Latest Developments
13.8 Qilu Pharmaceutical
13.8.1 Qilu Pharmaceutical Company Information
13.8.2 Qilu Pharmaceutical Palonosetron Product Portfolios and Specifications
13.8.3 Qilu Pharmaceutical Palonosetron Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Qilu Pharmaceutical Main Business Overview
13.8.5 Qilu Pharmaceutical Latest Developments
13.9 Jiangsu Aosaikang Pharmaceutical
13.9.1 Jiangsu Aosaikang Pharmaceutical Company Information
13.9.2 Jiangsu Aosaikang Pharmaceutical Palonosetron Product Portfolios and Specifications
13.9.3 Jiangsu Aosaikang Pharmaceutical Palonosetron Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Jiangsu Aosaikang Pharmaceutical Main Business Overview
13.9.5 Jiangsu Aosaikang Pharmaceutical Latest Developments
13.10 Sichuan Hairong Pharmaceutical
13.10.1 Sichuan Hairong Pharmaceutical Company Information
13.10.2 Sichuan Hairong Pharmaceutical Palonosetron Product Portfolios and Specifications
13.10.3 Sichuan Hairong Pharmaceutical Palonosetron Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Sichuan Hairong Pharmaceutical Main Business Overview
13.10.5 Sichuan Hairong Pharmaceutical Latest Developments
13.11 Exela Pharma
13.11.1 Exela Pharma Company Information
13.11.2 Exela Pharma Palonosetron Product Portfolios and Specifications
13.11.3 Exela Pharma Palonosetron Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Exela Pharma Main Business Overview
13.11.5 Exela Pharma Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Palonosetron Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Palonosetron Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Injection 0.25 mg/5 mL
Table 4. Major Players of Injection 20 mcg/kg (max 1.5 mg)
Table 5. Global Palonosetron Sales by Type (2020-2025) & (K Units)
Table 6. Global Palonosetron Sales Market Share by Type (2020-2025)
Table 7. Global Palonosetron Revenue by Type (2020-2025) & ($ million)
Table 8. Global Palonosetron Revenue Market Share by Type (2020-2025)
Table 9. Global Palonosetron Sale Price by Type (2020-2025) & (USD/Unit)
Table 10. Global Palonosetron Sale by Application (2020-2025) & (K Units)
Table 11. Global Palonosetron Sale Market Share by Application (2020-2025)
Table 12. Global Palonosetron Revenue by Application (2020-2025) & ($ million)
Table 13. Global Palonosetron Revenue Market Share by Application (2020-2025)
Table 14. Global Palonosetron Sale Price by Application (2020-2025) & (USD/Unit)
Table 15. Global Palonosetron Sales by Company (2020-2025) & (K Units)
Table 16. Global Palonosetron Sales Market Share by Company (2020-2025)
Table 17. Global Palonosetron Revenue by Company (2020-2025) & ($ millions)
Table 18. Global Palonosetron Revenue Market Share by Company (2020-2025)
Table 19. Global Palonosetron Sale Price by Company (2020-2025) & (USD/Unit)
Table 20. Key Manufacturers Palonosetron Producing Area Distribution and Sales Area
Table 21. Players Palonosetron Products Offered
Table 22. Palonosetron Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Palonosetron Sales by Geographic Region (2020-2025) & (K Units)
Table 26. Global Palonosetron Sales Market Share Geographic Region (2020-2025)
Table 27. Global Palonosetron Revenue by Geographic Region (2020-2025) & ($ millions)
Table 28. Global Palonosetron Revenue Market Share by Geographic Region (2020-2025)
Table 29. Global Palonosetron Sales by Country/Region (2020-2025) & (K Units)
Table 30. Global Palonosetron Sales Market Share by Country/Region (2020-2025)
Table 31. Global Palonosetron Revenue by Country/Region (2020-2025) & ($ millions)
Table 32. Global Palonosetron Revenue Market Share by Country/Region (2020-2025)
Table 33. Americas Palonosetron Sales by Country (2020-2025) & (K Units)
Table 34. Americas Palonosetron Sales Market Share by Country (2020-2025)
Table 35. Americas Palonosetron Revenue by Country (2020-2025) & ($ millions)
Table 36. Americas Palonosetron Sales by Type (2020-2025) & (K Units)
Table 37. Americas Palonosetron Sales by Application (2020-2025) & (K Units)
Table 38. APAC Palonosetron Sales by Region (2020-2025) & (K Units)
Table 39. APAC Palonosetron Sales Market Share by Region (2020-2025)
Table 40. APAC Palonosetron Revenue by Region (2020-2025) & ($ millions)
Table 41. APAC Palonosetron Sales by Type (2020-2025) & (K Units)
Table 42. APAC Palonosetron Sales by Application (2020-2025) & (K Units)
Table 43. Europe Palonosetron Sales by Country (2020-2025) & (K Units)
Table 44. Europe Palonosetron Revenue by Country (2020-2025) & ($ millions)
Table 45. Europe Palonosetron Sales by Type (2020-2025) & (K Units)
Table 46. Europe Palonosetron Sales by Application (2020-2025) & (K Units)
Table 47. Middle East & Africa Palonosetron Sales by Country (2020-2025) & (K Units)
Table 48. Middle East & Africa Palonosetron Revenue Market Share by Country (2020-2025)
Table 49. Middle East & Africa Palonosetron Sales by Type (2020-2025) & (K Units)
Table 50. Middle East & Africa Palonosetron Sales by Application (2020-2025) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of Palonosetron
Table 52. Key Market Challenges & Risks of Palonosetron
Table 53. Key Industry Trends of Palonosetron
Table 54. Palonosetron Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Palonosetron Distributors List
Table 57. Palonosetron Customer List
Table 58. Global Palonosetron Sales Forecast by Region (2026-2031) & (K Units)
Table 59. Global Palonosetron Revenue Forecast by Region (2026-2031) & ($ millions)
Table 60. Americas Palonosetron Sales Forecast by Country (2026-2031) & (K Units)
Table 61. Americas Palonosetron Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 62. APAC Palonosetron Sales Forecast by Region (2026-2031) & (K Units)
Table 63. APAC Palonosetron Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 64. Europe Palonosetron Sales Forecast by Country (2026-2031) & (K Units)
Table 65. Europe Palonosetron Revenue Forecast by Country (2026-2031) & ($ millions)
Table 66. Middle East & Africa Palonosetron Sales Forecast by Country (2026-2031) & (K Units)
Table 67. Middle East & Africa Palonosetron Revenue Forecast by Country (2026-2031) & ($ millions)
Table 68. Global Palonosetron Sales Forecast by Type (2026-2031) & (K Units)
Table 69. Global Palonosetron Revenue Forecast by Type (2026-2031) & ($ millions)
Table 70. Global Palonosetron Sales Forecast by Application (2026-2031) & (K Units)
Table 71. Global Palonosetron Revenue Forecast by Application (2026-2031) & ($ millions)
Table 72. Helsinn Therapeutics Basic Information, Palonosetron Manufacturing Base, Sales Area and Its Competitors
Table 73. Helsinn Therapeutics Palonosetron Product Portfolios and Specifications
Table 74. Helsinn Therapeutics Palonosetron Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 75. Helsinn Therapeutics Main Business
Table 76. Helsinn Therapeutics Latest Developments
Table 77. Teva Basic Information, Palonosetron Manufacturing Base, Sales Area and Its Competitors
Table 78. Teva Palonosetron Product Portfolios and Specifications
Table 79. Teva Palonosetron Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 80. Teva Main Business
Table 81. Teva Latest Developments
Table 82. Dr. Reddys Laboratories Basic Information, Palonosetron Manufacturing Base, Sales Area and Its Competitors
Table 83. Dr. Reddys Laboratories Palonosetron Product Portfolios and Specifications
Table 84. Dr. Reddys Laboratories Palonosetron Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 85. Dr. Reddys Laboratories Main Business
Table 86. Dr. Reddys Laboratories Latest Developments
Table 87. Cipla Basic Information, Palonosetron Manufacturing Base, Sales Area and Its Competitors
Table 88. Cipla Palonosetron Product Portfolios and Specifications
Table 89. Cipla Palonosetron Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 90. Cipla Main Business
Table 91. Cipla Latest Developments
Table 92. Pfizer Basic Information, Palonosetron Manufacturing Base, Sales Area and Its Competitors
Table 93. Pfizer Palonosetron Product Portfolios and Specifications
Table 94. Pfizer Palonosetron Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 95. Pfizer Main Business
Table 96. Pfizer Latest Developments
Table 97. Sagent Pharmaceuticals Basic Information, Palonosetron Manufacturing Base, Sales Area and Its Competitors
Table 98. Sagent Pharmaceuticals Palonosetron Product Portfolios and Specifications
Table 99. Sagent Pharmaceuticals Palonosetron Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 100. Sagent Pharmaceuticals Main Business
Table 101. Sagent Pharmaceuticals Latest Developments
Table 102. Fresenius Kabi Basic Information, Palonosetron Manufacturing Base, Sales Area and Its Competitors
Table 103. Fresenius Kabi Palonosetron Product Portfolios and Specifications
Table 104. Fresenius Kabi Palonosetron Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 105. Fresenius Kabi Main Business
Table 106. Fresenius Kabi Latest Developments
Table 107. Qilu Pharmaceutical Basic Information, Palonosetron Manufacturing Base, Sales Area and Its Competitors
Table 108. Qilu Pharmaceutical Palonosetron Product Portfolios and Specifications
Table 109. Qilu Pharmaceutical Palonosetron Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 110. Qilu Pharmaceutical Main Business
Table 111. Qilu Pharmaceutical Latest Developments
Table 112. Jiangsu Aosaikang Pharmaceutical Basic Information, Palonosetron Manufacturing Base, Sales Area and Its Competitors
Table 113. Jiangsu Aosaikang Pharmaceutical Palonosetron Product Portfolios and Specifications
Table 114. Jiangsu Aosaikang Pharmaceutical Palonosetron Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 115. Jiangsu Aosaikang Pharmaceutical Main Business
Table 116. Jiangsu Aosaikang Pharmaceutical Latest Developments
Table 117. Sichuan Hairong Pharmaceutical Basic Information, Palonosetron Manufacturing Base, Sales Area and Its Competitors
Table 118. Sichuan Hairong Pharmaceutical Palonosetron Product Portfolios and Specifications
Table 119. Sichuan Hairong Pharmaceutical Palonosetron Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 120. Sichuan Hairong Pharmaceutical Main Business
Table 121. Sichuan Hairong Pharmaceutical Latest Developments
Table 122. Exela Pharma Basic Information, Palonosetron Manufacturing Base, Sales Area and Its Competitors
Table 123. Exela Pharma Palonosetron Product Portfolios and Specifications
Table 124. Exela Pharma Palonosetron Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 125. Exela Pharma Main Business
Table 126. Exela Pharma Latest Developments
Table 1. Palonosetron Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Palonosetron Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Injection 0.25 mg/5 mL
Table 4. Major Players of Injection 20 mcg/kg (max 1.5 mg)
Table 5. Global Palonosetron Sales by Type (2020-2025) & (K Units)
Table 6. Global Palonosetron Sales Market Share by Type (2020-2025)
Table 7. Global Palonosetron Revenue by Type (2020-2025) & ($ million)
Table 8. Global Palonosetron Revenue Market Share by Type (2020-2025)
Table 9. Global Palonosetron Sale Price by Type (2020-2025) & (USD/Unit)
Table 10. Global Palonosetron Sale by Application (2020-2025) & (K Units)
Table 11. Global Palonosetron Sale Market Share by Application (2020-2025)
Table 12. Global Palonosetron Revenue by Application (2020-2025) & ($ million)
Table 13. Global Palonosetron Revenue Market Share by Application (2020-2025)
Table 14. Global Palonosetron Sale Price by Application (2020-2025) & (USD/Unit)
Table 15. Global Palonosetron Sales by Company (2020-2025) & (K Units)
Table 16. Global Palonosetron Sales Market Share by Company (2020-2025)
Table 17. Global Palonosetron Revenue by Company (2020-2025) & ($ millions)
Table 18. Global Palonosetron Revenue Market Share by Company (2020-2025)
Table 19. Global Palonosetron Sale Price by Company (2020-2025) & (USD/Unit)
Table 20. Key Manufacturers Palonosetron Producing Area Distribution and Sales Area
Table 21. Players Palonosetron Products Offered
Table 22. Palonosetron Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Palonosetron Sales by Geographic Region (2020-2025) & (K Units)
Table 26. Global Palonosetron Sales Market Share Geographic Region (2020-2025)
Table 27. Global Palonosetron Revenue by Geographic Region (2020-2025) & ($ millions)
Table 28. Global Palonosetron Revenue Market Share by Geographic Region (2020-2025)
Table 29. Global Palonosetron Sales by Country/Region (2020-2025) & (K Units)
Table 30. Global Palonosetron Sales Market Share by Country/Region (2020-2025)
Table 31. Global Palonosetron Revenue by Country/Region (2020-2025) & ($ millions)
Table 32. Global Palonosetron Revenue Market Share by Country/Region (2020-2025)
Table 33. Americas Palonosetron Sales by Country (2020-2025) & (K Units)
Table 34. Americas Palonosetron Sales Market Share by Country (2020-2025)
Table 35. Americas Palonosetron Revenue by Country (2020-2025) & ($ millions)
Table 36. Americas Palonosetron Sales by Type (2020-2025) & (K Units)
Table 37. Americas Palonosetron Sales by Application (2020-2025) & (K Units)
Table 38. APAC Palonosetron Sales by Region (2020-2025) & (K Units)
Table 39. APAC Palonosetron Sales Market Share by Region (2020-2025)
Table 40. APAC Palonosetron Revenue by Region (2020-2025) & ($ millions)
Table 41. APAC Palonosetron Sales by Type (2020-2025) & (K Units)
Table 42. APAC Palonosetron Sales by Application (2020-2025) & (K Units)
Table 43. Europe Palonosetron Sales by Country (2020-2025) & (K Units)
Table 44. Europe Palonosetron Revenue by Country (2020-2025) & ($ millions)
Table 45. Europe Palonosetron Sales by Type (2020-2025) & (K Units)
Table 46. Europe Palonosetron Sales by Application (2020-2025) & (K Units)
Table 47. Middle East & Africa Palonosetron Sales by Country (2020-2025) & (K Units)
Table 48. Middle East & Africa Palonosetron Revenue Market Share by Country (2020-2025)
Table 49. Middle East & Africa Palonosetron Sales by Type (2020-2025) & (K Units)
Table 50. Middle East & Africa Palonosetron Sales by Application (2020-2025) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of Palonosetron
Table 52. Key Market Challenges & Risks of Palonosetron
Table 53. Key Industry Trends of Palonosetron
Table 54. Palonosetron Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Palonosetron Distributors List
Table 57. Palonosetron Customer List
Table 58. Global Palonosetron Sales Forecast by Region (2026-2031) & (K Units)
Table 59. Global Palonosetron Revenue Forecast by Region (2026-2031) & ($ millions)
Table 60. Americas Palonosetron Sales Forecast by Country (2026-2031) & (K Units)
Table 61. Americas Palonosetron Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 62. APAC Palonosetron Sales Forecast by Region (2026-2031) & (K Units)
Table 63. APAC Palonosetron Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 64. Europe Palonosetron Sales Forecast by Country (2026-2031) & (K Units)
Table 65. Europe Palonosetron Revenue Forecast by Country (2026-2031) & ($ millions)
Table 66. Middle East & Africa Palonosetron Sales Forecast by Country (2026-2031) & (K Units)
Table 67. Middle East & Africa Palonosetron Revenue Forecast by Country (2026-2031) & ($ millions)
Table 68. Global Palonosetron Sales Forecast by Type (2026-2031) & (K Units)
Table 69. Global Palonosetron Revenue Forecast by Type (2026-2031) & ($ millions)
Table 70. Global Palonosetron Sales Forecast by Application (2026-2031) & (K Units)
Table 71. Global Palonosetron Revenue Forecast by Application (2026-2031) & ($ millions)
Table 72. Helsinn Therapeutics Basic Information, Palonosetron Manufacturing Base, Sales Area and Its Competitors
Table 73. Helsinn Therapeutics Palonosetron Product Portfolios and Specifications
Table 74. Helsinn Therapeutics Palonosetron Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 75. Helsinn Therapeutics Main Business
Table 76. Helsinn Therapeutics Latest Developments
Table 77. Teva Basic Information, Palonosetron Manufacturing Base, Sales Area and Its Competitors
Table 78. Teva Palonosetron Product Portfolios and Specifications
Table 79. Teva Palonosetron Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 80. Teva Main Business
Table 81. Teva Latest Developments
Table 82. Dr. Reddys Laboratories Basic Information, Palonosetron Manufacturing Base, Sales Area and Its Competitors
Table 83. Dr. Reddys Laboratories Palonosetron Product Portfolios and Specifications
Table 84. Dr. Reddys Laboratories Palonosetron Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 85. Dr. Reddys Laboratories Main Business
Table 86. Dr. Reddys Laboratories Latest Developments
Table 87. Cipla Basic Information, Palonosetron Manufacturing Base, Sales Area and Its Competitors
Table 88. Cipla Palonosetron Product Portfolios and Specifications
Table 89. Cipla Palonosetron Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 90. Cipla Main Business
Table 91. Cipla Latest Developments
Table 92. Pfizer Basic Information, Palonosetron Manufacturing Base, Sales Area and Its Competitors
Table 93. Pfizer Palonosetron Product Portfolios and Specifications
Table 94. Pfizer Palonosetron Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 95. Pfizer Main Business
Table 96. Pfizer Latest Developments
Table 97. Sagent Pharmaceuticals Basic Information, Palonosetron Manufacturing Base, Sales Area and Its Competitors
Table 98. Sagent Pharmaceuticals Palonosetron Product Portfolios and Specifications
Table 99. Sagent Pharmaceuticals Palonosetron Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 100. Sagent Pharmaceuticals Main Business
Table 101. Sagent Pharmaceuticals Latest Developments
Table 102. Fresenius Kabi Basic Information, Palonosetron Manufacturing Base, Sales Area and Its Competitors
Table 103. Fresenius Kabi Palonosetron Product Portfolios and Specifications
Table 104. Fresenius Kabi Palonosetron Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 105. Fresenius Kabi Main Business
Table 106. Fresenius Kabi Latest Developments
Table 107. Qilu Pharmaceutical Basic Information, Palonosetron Manufacturing Base, Sales Area and Its Competitors
Table 108. Qilu Pharmaceutical Palonosetron Product Portfolios and Specifications
Table 109. Qilu Pharmaceutical Palonosetron Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 110. Qilu Pharmaceutical Main Business
Table 111. Qilu Pharmaceutical Latest Developments
Table 112. Jiangsu Aosaikang Pharmaceutical Basic Information, Palonosetron Manufacturing Base, Sales Area and Its Competitors
Table 113. Jiangsu Aosaikang Pharmaceutical Palonosetron Product Portfolios and Specifications
Table 114. Jiangsu Aosaikang Pharmaceutical Palonosetron Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 115. Jiangsu Aosaikang Pharmaceutical Main Business
Table 116. Jiangsu Aosaikang Pharmaceutical Latest Developments
Table 117. Sichuan Hairong Pharmaceutical Basic Information, Palonosetron Manufacturing Base, Sales Area and Its Competitors
Table 118. Sichuan Hairong Pharmaceutical Palonosetron Product Portfolios and Specifications
Table 119. Sichuan Hairong Pharmaceutical Palonosetron Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 120. Sichuan Hairong Pharmaceutical Main Business
Table 121. Sichuan Hairong Pharmaceutical Latest Developments
Table 122. Exela Pharma Basic Information, Palonosetron Manufacturing Base, Sales Area and Its Competitors
Table 123. Exela Pharma Palonosetron Product Portfolios and Specifications
Table 124. Exela Pharma Palonosetron Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 125. Exela Pharma Main Business
Table 126. Exela Pharma Latest Developments
LIST OF FIGURES
Figure 1. Picture of Palonosetron
Figure 2. Palonosetron Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Palonosetron Sales Growth Rate 2020-2031 (K Units)
Figure 7. Global Palonosetron Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Palonosetron Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Palonosetron Sales Market Share by Country/Region (2024)
Figure 10. Palonosetron Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Injection 0.25 mg/5 mL
Figure 12. Product Picture of Injection 20 mcg/kg (max 1.5 mg)
Figure 13. Global Palonosetron Sales Market Share by Type in 2025
Figure 14. Global Palonosetron Revenue Market Share by Type (2020-2025)
Figure 15. Palonosetron Consumed in Adults
Figure 16. Global Palonosetron Market: Adults (2020-2025) & (K Units)
Figure 17. Palonosetron Consumed in Children
Figure 18. Global Palonosetron Market: Children (2020-2025) & (K Units)
Figure 19. Global Palonosetron Sale Market Share by Application (2024)
Figure 20. Global Palonosetron Revenue Market Share by Application in 2025
Figure 21. Palonosetron Sales by Company in 2025 (K Units)
Figure 22. Global Palonosetron Sales Market Share by Company in 2025
Figure 23. Palonosetron Revenue by Company in 2025 ($ millions)
Figure 24. Global Palonosetron Revenue Market Share by Company in 2025
Figure 25. Global Palonosetron Sales Market Share by Geographic Region (2020-2025)
Figure 26. Global Palonosetron Revenue Market Share by Geographic Region in 2025
Figure 27. Americas Palonosetron Sales 2020-2025 (K Units)
Figure 28. Americas Palonosetron Revenue 2020-2025 ($ millions)
Figure 29. APAC Palonosetron Sales 2020-2025 (K Units)
Figure 30. APAC Palonosetron Revenue 2020-2025 ($ millions)
Figure 31. Europe Palonosetron Sales 2020-2025 (K Units)
Figure 32. Europe Palonosetron Revenue 2020-2025 ($ millions)
Figure 33. Middle East & Africa Palonosetron Sales 2020-2025 (K Units)
Figure 34. Middle East & Africa Palonosetron Revenue 2020-2025 ($ millions)
Figure 35. Americas Palonosetron Sales Market Share by Country in 2025
Figure 36. Americas Palonosetron Revenue Market Share by Country (2020-2025)
Figure 37. Americas Palonosetron Sales Market Share by Type (2020-2025)
Figure 38. Americas Palonosetron Sales Market Share by Application (2020-2025)
Figure 39. United States Palonosetron Revenue Growth 2020-2025 ($ millions)
Figure 40. Canada Palonosetron Revenue Growth 2020-2025 ($ millions)
Figure 41. Mexico Palonosetron Revenue Growth 2020-2025 ($ millions)
Figure 42. Brazil Palonosetron Revenue Growth 2020-2025 ($ millions)
Figure 43. APAC Palonosetron Sales Market Share by Region in 2025
Figure 44. APAC Palonosetron Revenue Market Share by Region (2020-2025)
Figure 45. APAC Palonosetron Sales Market Share by Type (2020-2025)
Figure 46. APAC Palonosetron Sales Market Share by Application (2020-2025)
Figure 47. China Palonosetron Revenue Growth 2020-2025 ($ millions)
Figure 48. Japan Palonosetron Revenue Growth 2020-2025 ($ millions)
Figure 49. South Korea Palonosetron Revenue Growth 2020-2025 ($ millions)
Figure 50. Southeast Asia Palonosetron Revenue Growth 2020-2025 ($ millions)
Figure 51. India Palonosetron Revenue Growth 2020-2025 ($ millions)
Figure 52. Australia Palonosetron Revenue Growth 2020-2025 ($ millions)
Figure 53. China Taiwan Palonosetron Revenue Growth 2020-2025 ($ millions)
Figure 54. Europe Palonosetron Sales Market Share by Country in 2025
Figure 55. Europe Palonosetron Revenue Market Share by Country (2020-2025)
Figure 56. Europe Palonosetron Sales Market Share by Type (2020-2025)
Figure 57. Europe Palonosetron Sales Market Share by Application (2020-2025)
Figure 58. Germany Palonosetron Revenue Growth 2020-2025 ($ millions)
Figure 59. France Palonosetron Revenue Growth 2020-2025 ($ millions)
Figure 60. UK Palonosetron Revenue Growth 2020-2025 ($ millions)
Figure 61. Italy Palonosetron Revenue Growth 2020-2025 ($ millions)
Figure 62. Russia Palonosetron Revenue Growth 2020-2025 ($ millions)
Figure 63. Middle East & Africa Palonosetron Sales Market Share by Country (2020-2025)
Figure 64. Middle East & Africa Palonosetron Sales Market Share by Type (2020-2025)
Figure 65. Middle East & Africa Palonosetron Sales Market Share by Application (2020-2025)
Figure 66. Egypt Palonosetron Revenue Growth 2020-2025 ($ millions)
Figure 67. South Africa Palonosetron Revenue Growth 2020-2025 ($ millions)
Figure 68. Israel Palonosetron Revenue Growth 2020-2025 ($ millions)
Figure 69. Turkey Palonosetron Revenue Growth 2020-2025 ($ millions)
Figure 70. GCC Countries Palonosetron Revenue Growth 2020-2025 ($ millions)
Figure 71. Manufacturing Cost Structure Analysis of Palonosetron in 2025
Figure 72. Manufacturing Process Analysis of Palonosetron
Figure 73. Industry Chain Structure of Palonosetron
Figure 74. Channels of Distribution
Figure 75. Global Palonosetron Sales Market Forecast by Region (2026-2031)
Figure 76. Global Palonosetron Revenue Market Share Forecast by Region (2026-2031)
Figure 77. Global Palonosetron Sales Market Share Forecast by Type (2026-2031)
Figure 78. Global Palonosetron Revenue Market Share Forecast by Type (2026-2031)
Figure 79. Global Palonosetron Sales Market Share Forecast by Application (2026-2031)
Figure 80. Global Palonosetron Revenue Market Share Forecast by Application (2026-2031)
Figure 1. Picture of Palonosetron
Figure 2. Palonosetron Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Palonosetron Sales Growth Rate 2020-2031 (K Units)
Figure 7. Global Palonosetron Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Palonosetron Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Palonosetron Sales Market Share by Country/Region (2024)
Figure 10. Palonosetron Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Injection 0.25 mg/5 mL
Figure 12. Product Picture of Injection 20 mcg/kg (max 1.5 mg)
Figure 13. Global Palonosetron Sales Market Share by Type in 2025
Figure 14. Global Palonosetron Revenue Market Share by Type (2020-2025)
Figure 15. Palonosetron Consumed in Adults
Figure 16. Global Palonosetron Market: Adults (2020-2025) & (K Units)
Figure 17. Palonosetron Consumed in Children
Figure 18. Global Palonosetron Market: Children (2020-2025) & (K Units)
Figure 19. Global Palonosetron Sale Market Share by Application (2024)
Figure 20. Global Palonosetron Revenue Market Share by Application in 2025
Figure 21. Palonosetron Sales by Company in 2025 (K Units)
Figure 22. Global Palonosetron Sales Market Share by Company in 2025
Figure 23. Palonosetron Revenue by Company in 2025 ($ millions)
Figure 24. Global Palonosetron Revenue Market Share by Company in 2025
Figure 25. Global Palonosetron Sales Market Share by Geographic Region (2020-2025)
Figure 26. Global Palonosetron Revenue Market Share by Geographic Region in 2025
Figure 27. Americas Palonosetron Sales 2020-2025 (K Units)
Figure 28. Americas Palonosetron Revenue 2020-2025 ($ millions)
Figure 29. APAC Palonosetron Sales 2020-2025 (K Units)
Figure 30. APAC Palonosetron Revenue 2020-2025 ($ millions)
Figure 31. Europe Palonosetron Sales 2020-2025 (K Units)
Figure 32. Europe Palonosetron Revenue 2020-2025 ($ millions)
Figure 33. Middle East & Africa Palonosetron Sales 2020-2025 (K Units)
Figure 34. Middle East & Africa Palonosetron Revenue 2020-2025 ($ millions)
Figure 35. Americas Palonosetron Sales Market Share by Country in 2025
Figure 36. Americas Palonosetron Revenue Market Share by Country (2020-2025)
Figure 37. Americas Palonosetron Sales Market Share by Type (2020-2025)
Figure 38. Americas Palonosetron Sales Market Share by Application (2020-2025)
Figure 39. United States Palonosetron Revenue Growth 2020-2025 ($ millions)
Figure 40. Canada Palonosetron Revenue Growth 2020-2025 ($ millions)
Figure 41. Mexico Palonosetron Revenue Growth 2020-2025 ($ millions)
Figure 42. Brazil Palonosetron Revenue Growth 2020-2025 ($ millions)
Figure 43. APAC Palonosetron Sales Market Share by Region in 2025
Figure 44. APAC Palonosetron Revenue Market Share by Region (2020-2025)
Figure 45. APAC Palonosetron Sales Market Share by Type (2020-2025)
Figure 46. APAC Palonosetron Sales Market Share by Application (2020-2025)
Figure 47. China Palonosetron Revenue Growth 2020-2025 ($ millions)
Figure 48. Japan Palonosetron Revenue Growth 2020-2025 ($ millions)
Figure 49. South Korea Palonosetron Revenue Growth 2020-2025 ($ millions)
Figure 50. Southeast Asia Palonosetron Revenue Growth 2020-2025 ($ millions)
Figure 51. India Palonosetron Revenue Growth 2020-2025 ($ millions)
Figure 52. Australia Palonosetron Revenue Growth 2020-2025 ($ millions)
Figure 53. China Taiwan Palonosetron Revenue Growth 2020-2025 ($ millions)
Figure 54. Europe Palonosetron Sales Market Share by Country in 2025
Figure 55. Europe Palonosetron Revenue Market Share by Country (2020-2025)
Figure 56. Europe Palonosetron Sales Market Share by Type (2020-2025)
Figure 57. Europe Palonosetron Sales Market Share by Application (2020-2025)
Figure 58. Germany Palonosetron Revenue Growth 2020-2025 ($ millions)
Figure 59. France Palonosetron Revenue Growth 2020-2025 ($ millions)
Figure 60. UK Palonosetron Revenue Growth 2020-2025 ($ millions)
Figure 61. Italy Palonosetron Revenue Growth 2020-2025 ($ millions)
Figure 62. Russia Palonosetron Revenue Growth 2020-2025 ($ millions)
Figure 63. Middle East & Africa Palonosetron Sales Market Share by Country (2020-2025)
Figure 64. Middle East & Africa Palonosetron Sales Market Share by Type (2020-2025)
Figure 65. Middle East & Africa Palonosetron Sales Market Share by Application (2020-2025)
Figure 66. Egypt Palonosetron Revenue Growth 2020-2025 ($ millions)
Figure 67. South Africa Palonosetron Revenue Growth 2020-2025 ($ millions)
Figure 68. Israel Palonosetron Revenue Growth 2020-2025 ($ millions)
Figure 69. Turkey Palonosetron Revenue Growth 2020-2025 ($ millions)
Figure 70. GCC Countries Palonosetron Revenue Growth 2020-2025 ($ millions)
Figure 71. Manufacturing Cost Structure Analysis of Palonosetron in 2025
Figure 72. Manufacturing Process Analysis of Palonosetron
Figure 73. Industry Chain Structure of Palonosetron
Figure 74. Channels of Distribution
Figure 75. Global Palonosetron Sales Market Forecast by Region (2026-2031)
Figure 76. Global Palonosetron Revenue Market Share Forecast by Region (2026-2031)
Figure 77. Global Palonosetron Sales Market Share Forecast by Type (2026-2031)
Figure 78. Global Palonosetron Revenue Market Share Forecast by Type (2026-2031)
Figure 79. Global Palonosetron Sales Market Share Forecast by Application (2026-2031)
Figure 80. Global Palonosetron Revenue Market Share Forecast by Application (2026-2031)
